Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting?
- PMID: 30166893
- PMCID: PMC6112334
- DOI: 10.1016/j.ehj.2018.01.002
Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting?
Abstract
Background: Angina symptom in patients with ischemic cardiomyopathy (ICM) after coronary artery bypass grafting (CABG) surgery is a major challenging problem in practice. The choice among different treatment modalities available can be judged by different parameters especially measuring the risk/cost ratio to achieve the benefit. Enhanced external counter pulsation (EECP) is one of safest noninvasive modality for treatment of angina as well as it has an anti-failure effect.
Patients and method: 42 patients with ICM after CABG were suffering from stable angina and were treated at Al-Hayat Cardiology Centre in Tanta City (ACC). 20 patients of them (group A) received 35 sessions of EECP plus their anti-ischemic and anti-failure treatment, while the other 22 patients (group B) received only medical treatment and were followed up for 3 months regarding their angina class, functional class, frequency of angina attack, frequency of sublingual nitrate and rate of rehospitalization when needed during follow up period.
Results: Despite both groups had nearly similar severity of symptoms regarding the CCS class and NYHA class, yet patients in group A experienced significant improvement in comparison to patients in group B (p-value = .005, p-value = .002 respectively), and this was reflected on frequency of angina and need for sublingual nitrates per week which showed significant decrease in group A (p-value = .001).
Conclusion: As a non-invasive treatment modality EECP is very effective in improving the symptoms of angina and heart failure when combined with medical treatment in patients with ICM after CABG.
Keywords: Angina; EECP; Heart failure; Ischemic cardiomyopathy.
Figures
References
-
- Mannheimer C., Camici P., Chester M.R. The problem of chronic refractory angina. Report from the ESC joint study group on the treatment of refractory angina. Eur Heart J. 2002;23:355–370. - PubMed
-
- Saririan M., Eisenberg M.J. Myocardial laser revascularization for the treatment of end-stage coronary artery disease. J Am Coll Cardiol. 2003;41:173–183. - PubMed
-
- Henry T.D., Annex B.H., McKendall G.R. The VIVA trial. Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107:1359–1365. - PubMed
-
- Ekre O., Norell H., Währborg P. Spinal cord stimulation and coronary artery bypass grafting provide an equal improvement in the quality of life. Data from the ESBY study. Eur Heart J. 2002;23:1938–1945. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials